Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2010

Mar 3, 2010

30071_dirs_2010-03-03_91593178-b167-4dbd-b9f1-608954bf2364.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-03-01

Reporting Person: Farrell Michael J. (Sr. Vice President)

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 1 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
ResMed NQ Stock Options $38.50 2016-02-03 ResMed Common Stock (15000) Direct
ResMed NQ Stock Options $46.19 2013-11-10 ResMed Common Stock (17000) Direct
ResMed NQ Stock Options $43.42 2014-08-01 ResMed Common Stock (25000) Direct
ResMed NQ Stock Options $42.05 2014-11-07 ResMed Common Stock (4000) Direct
ResMed NQ Stock Options $43.35 2015-10-01 ResMed Common Stock (10000) Direct
ResMed NQ Stock Options $31.04 2015-11-20 ResMed Common Stock (55000) Direct

Footnotes

F1: Options vest 1/4 annually on the anniversary of the grant. Represents date options first became exercisable.